SA
AGN

Steadfast Advisors’s Allergan plc AGN Stock Holding History

Steadfast Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,549
Closed -$4.5M – 58
2016
Q3 		$4.5M Buy
19,549
+4,421
+29% +$1.08M 1.91% 23
2016
Q2 		$3.5M Buy
15,128
+3,855
+34% +$889K 2.15% 18
2016
Q1 		$3.02M Sell
11,273
-17,793
-61% -$5.09M 1.79% 18
2015
Q4 		$9.08M Sell
29,066
-8,114
-22% -$2.42M 4.22% 6
2015
Q3 		$10.1M Sell
37,180
-39,920
-52% -$12.3M 4.8% 4
2015
Q2 		$23.4M Sell
77,100
-24,016
-24% -$7.16M 8.12% 1
2015
Q1 		$30.1M Buy
101,116
+66,081
+189% +$18.8M 9.84% 1
2014
Q4 		$9.02M Sell
35,035
-19,075
-35% -$4.77M 3.14% 8
2014
Q3 		$13.1M Sell
54,110
-27,582
-34% -$6.17M 4.9% 3
2014
Q2 		$18.2M Buy
81,692
+1,847
+2% +$382K 6.31% 3
2014
Q1 		$16.4M Buy
79,845
+25,069
+46% +$4.97M 7.41% 1
2013
Q4 		$9.2M Buy
+54,776
New +$8.56M 4.35% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Steadfast Advisors's AGN Position: Q4 2016 in Review

Steadfast Advisors sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 19,549 shares — an estimated $4.5M sold.

Steadfast Advisors first reported a position in AGN in Q4 2013 and held it in 12 quarters. The position peaked at $30.1M in Q1 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Steadfast Advisors reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Steadfast Advisors sold 19,549 Allergan plc shares in Q4 2016, an estimated $4.5M.
  • Steadfast Advisors first reported a position in Allergan plc in Q4 2013 and held it in 12 quarters.
  • Steadfast Advisors's Allergan plc position peaked at $30.1M in Q1 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Steadfast Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.